News

deltaDOT has announced that it has completed its private equity funding round, raising £2.3 million (US$4.1 million).

Scientists have announced that they are investigating a class of pharmaceuticals that may well improve memory function, including those with Alzheimer's disease, and address some of the underlying causes of memory loss rather than today's drugs that simply treat symptoms.

Odyssey to provide the NIH Chemical Genomics Center with access to proprietary human cell lines with state-of-the-art technology for screening biochemical pathways in living cells

Sidmap signs aggrements with Harvard Medical School's Joslin Diabetes Center and the University of Utah.

ActiveSight has announced the addition of renin to their portfolio of "ready-to-go" protein crystals for drug discovery.

GenTel to market and sell the ULS labeling reagents under their brand name PANDEIA™ in diverse kit formats.

Biodesign Institute's Center for BioOptical Nanotechnology is purchasing CombiMatrix' equipment and funding development of the synthesizer.

Both parties agree to co-market the rapid generation of monoclonal antibodies by Antibodies by Design and the complementary peptide-based services and products from JPT.

Instruments, which originate from the recently acquired company Argonaut, will be used by chemists to enhance the processes used in the development of pharmaceuticals.

Thermo has purchased Ionalytics Corporation a developer of a dynamic ion filtering device used with mass spectrometers in bioanalysis, proteomics and drug discovery.